Image

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)

Recruiting
45-65 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if an individualized lifestyle intervention works to improve weight, diet, physical activity, cardiovascular health, health-related quality of life, and cost-effectiveness in overweight and obese adults aged 45-65 years.

The main questions it aims to answer are:

Does the intervention lead to sustained weight loss after 18 months?

Does the intervention improve cardiovascular risk factors, metabolic markers, and health-related quality of life compared to general written advice?

Is the intervention cost-effective?

Researchers will compare the individualized lifestyle intervention to a control group that receives general written advice on physical activity and diet to see if the intervention provides greater long-term health and economic benefits.

Participants will:

Attend counseling sessions with a health promoter Take part in supervised aerobic and resistance training with a physiotherapist Use swimming facilities and participate in the Lifestyle School Access a digital health coach and the online Lifestyle Tool Complete measurements of body weight, diet, physical activity, and cardiovascular health markers (waist-to-hip ratio, blood pressure, blood lipids, fasting glucose, HbA1c, CRP, and liver enzymes) Complete assessments of resting energy expenditure, aerobic fitness, muscle strength, motivation, and health-related quality of life Provide blood samples at baseline, 6 months, and 18 months for dietary biomarker analysis Contribute data for health economic evaluation to assess cost-effectiveness

Description

Background Overweight and obese adults, especially those with type 2 diabetes, have increased risk of cardiovascular disease (CVD). Lifestyle interventions with physical activity (PA) and diet improve CVD risk factors, but long-term behavior change is challenging. Individualized approaches are recommended, yet rarely implemented for both PA and diet in clinical practice.

Objectives

The study evaluates whether an individualized precision health intervention:

Produces greater weight loss at 6 months (short-term) and 18 months (long-term)

Improves cardiovascular risk factors, metabolic markers, diet, PA behaviors, fitness, and psychosocial outcomes

Is feasible and cost-effective compared to standard lifestyle advice

Study Design

Randomized controlled trial with two arms:

Intervention group: Individualized precision health program

Control group: Standard lifestyle advice

Total participants: 120 (60 per group), aged 45-65 years, BMI 28-34

Exclusion: known coronary artery disease, inability to participate in lifestyle interventions, or language barriers

Intervention (LI-PAD Precision Health):

Step 1: Individual Adaptation

Adjust recommendations for medical conditions, comorbidities, medications, psychosocial factors, preferences, readiness to change, and barriers/facilitators

Step 2: Individualized Advice

PA prescription based on accelerometry, VO₂max, and muscle strength

Dietary guidance based on food intake diaries and measured resting energy expenditure (REE)

Step 3: Support for Goal Achievement

Education and skill training

Behavioral support: health promoters, group sessions, face-to-face and online coaching, apps for diet and PA, nudging

Control Group:

Standard lifestyle advice: healthy diet, ≥300 min/week moderate-intensity aerobic PA, 2 sessions/week strength training

Outcome Measures:

Primary Outcome:

Change in body weight from baseline to 6 months and 18 months

Secondary Outcomes:

BMI, waist and hip circumference

Blood pressure

Blood markers: cardiometabolic (lipids, HbA1c, cholesterol, HDL, LDL; ASAT, ALAT, ALP, GGT, hs-CRP) and dietary intake biomarkers

Cardiorespiratory fitness and muscle strength

Behavioral measures: PA (accelerometry, SGPALS), diet (MiniMeal-Q, REE)

Psychosocial outcomes: health-related quality of life (EQ5D-3L, RAND-36), motivation, self-efficacy

Cost-effectiveness analysis based on BMI and secondary outcomes

Additional Outcomes (Intervention Group):

Feasibility: attendance, compliance, participant evaluation

Barriers and facilitators to behavioral change

GPS tracking of PA and dietary behavior

Assessments

Baseline, 6-month, and 18-month follow-ups

Anthropometry, REE, blood pressure, blood markers, fitness tests, accelerometry, questionnaires, and dietary logs

Statistical Analysis:

Multilevel mixed models for repeated measures

Linear and logistic regression for continuous and categorical variables

Structural equation modeling and partial least squares regression to explore relationships between intervention components and outcomes

Collaborators

Sahlgrenska University Hospital/Östra: health promoters, physiotherapists, biomedical analysts

University of Gothenburg: Food and Nutrition, Sport Science, metabolomics, health economics

National and international collaborators with expertise in PA, diet, and cardiovascular health

Summary

LI-PAD-Extended is an 18-month follow-up evaluating individualized precision health interventions. The study combines objective PA and dietary assessments with behavioral support and cost-effectiveness evaluation. This long-term follow-up allows assessment of sustained effects of precision lifestyle interventions on weight, cardiovascular risk, fitness, psychosocial outcomes, and economic efficiency.

Eligibility

Inclusion Criteria:

  • Adults aged 45-65 years at baseline of the original LI-PAD study
  • Body mass index (BMI) ≥28 and ≤34
  • Completed the original LI-PAD study
  • Able and willing to attend follow-up assessments and provide necessary data
  • Able and willing to provide informed consent

Exclusion Criteria:

  • Known coronary artery disease (clinical symptoms or earlier event)
  • Inability to understand the language used in the study
  • Inability to complete follow-up assessments at 18 months
  • Severe illness or medical condition that, in the investigator's opinion, precludes participation in follow-up assessments

Study details
    Overweight
    Obesity
    Prediabetic State

NCT07605169

Vastra Gotaland Region

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.